Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings